| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.21 | 0.0002 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.0006 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.26 | 0.0007 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0008 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.001 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |